PI3K signalling at the immune synapse asymmetric division and immunological memory.
PI3K signalling at the immune synapse asymmetric division and immunological memory.
批准号:
BB/F015461/1
负责人:
Klaus Okkenhaug
金额:
$97.59万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2008
资助国家:
英国
项目状态:
已结题
起止时间:
2008 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
T helper cells are master cells of the immune response. T cells are responsible for detecting infectious agents, be they bacteria, viruses or parasites; they are responsible for assessing the potential damage these infectious agents can cause, and to mount proportional and selective immune response to get rid of the infectious agent while causing minimal damage to the host. The T cells make this decision as they form conjugate with antigen presenting cells - that is cells that are specialised in devouring foreign particles, digesting them in to smaller fragments, and presenting these fragments to T cells. T cells respond by stimulating other cells of the immune response to secrete antibodies that eliminate the pathogen. Cytotoxic T cells act by killing infected host cells, thus incapacitating the pathogen inside. Both these cell types will be investigated as part of this proposal. T helper cell makes their decisions over several hours during which the T cell corresponds with an antigen presenting cell though a structure called the immune synapse. The synapse is a term immunologists have stolen from the field of neurobiology. Neurons transmit signals from one nerve to another through synapses, which in fact is what immune cells do as well. However, there are important differences. Immune cells are highly motile and travel through the lymph nodes and through different tissues, such as the skin and gut where infections agents may be found. This constant movement places additional constraints on T cells to form stable synapses - a bit like parachutists trying to grab each others hands while in freefall. p110delta belongs to a family of enzymes called phosphoinositide 3-kinases (PI3Ks for short). We have engineered mice in which the gene for p110delta is modified such that the enzyme is no longer functional. T cells from such mice are poor at forming conjugates with antigen presenting cells. Moreover, we have evidence that p110delta-deficient T cells fail to organise themselves in the right conformation to maximise their ability to read and interpret the signals provided by the antigen presenting cells. The first purpose of this grant is to more fully characterise these defects at the molecular level as it is at present not obvious why p110delta should be important for these functions. Next, we will determine how important this actually is for the ability of T cells to respond to infectious agents. We will also monitor how T cells respond after infection with a bacterium called Listeria monocytogenes. This bacterium is sometimes found in unpasteurised milk products, such as cheese, and can cause disease in humans. We will observe in T cells taken from infected mice whether they make functional conjugates with APCs and if they are capable of responding appropriately. In addition, we will test if p110delta-deficient T cells can divide in such a way that one cell becomes an effector cell (destined for a short life dedicated to immediate elimination of the infectious agent), whereas the other cell becomes a memory cell that waits in the background and is prepared to raise an even more immediate and effective response should the particular infectious agent be encountered again. This process is the basis for how vaccines work. Together, these experiments will examine how p110delta, a target for drugs being developed by the pharmaceutical industry, affects fundamental immune responses that protect from recurrent infections.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1146/annurev-immunol-032712-095946
发表时间:
2013
期刊:
Annual review of immunology
影响因子:
29.7
作者:
[Okkenhaug K]
通讯作者:
Okkenhaug K
DOI:
10.3389/fimmu.2018.01006
发表时间:
2018
期刊:
Frontiers in immunology
影响因子:
7.3
作者:
[Benson RA, Garcon F, Recino A, Ferdinand JR, Clatworthy MR, Waldmann H, Brewer JM, Okkenhaug K, Cooke A, Garside P, Wållberg M]
通讯作者:
Wållberg M
Pten loss in CD4 T cells enhances their helper function but does not lead to autoimmunity or lymphoma.
CD4 T细胞中的PTEN损失增强了其辅助功能,但不会导致自身免疫性或淋巴瘤。
DOI:
10.4049/jimmunol.1102116
发表时间:
2012-06-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Soond DR, Garçon F, Patton DT, Rolf J, Turner M, Scudamore C, Garden OA, Okkenhaug K]
通讯作者:
Okkenhaug K
DOI:
10.1126/scisignal.2001104
发表时间:
2010-08-10
期刊:
Science signaling
影响因子:
7.3
作者:
[Ramadani F, Bolland DJ, Garcon F, Emery JL, Vanhaesebroeck B, Corcoran AE, Okkenhaug K]
通讯作者:
Okkenhaug K
PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans.
PI3K p110delta在小鼠和人类的原发性和继发性免疫反应期间调节T细胞细胞因子的产生。
DOI:
10.1182/blood-2009-07-232330
发表时间:
2010-03-18
期刊:
Blood
影响因子:
20.3
作者:
[Soond DR, Bjørgo E, Moltu K, Dale VQ, Patton DT, Torgersen KM, Galleway F, Twomey B, Clark J, Gaston JS, Taskén K, Bunyard P, Okkenhaug K]
通讯作者:
Okkenhaug K
Enhancing T cell immunity to cancer metastasis
-
批准号:MR/Y013301/1
-
项目类别:Research Grant
-
资助金额:$317.71万
-
财政年份:2024
-
负责人:Klaus Okkenhaug
-
依托单位:
Novel mechanisms of regulatory T cell mediated suppression: a fundamental role for VPS34
-
批准号:BB/T007826/1
-
项目类别:Research Grant
-
资助金额:$81.35万
-
财政年份:2020
-
负责人:Klaus Okkenhaug
-
依托单位:
PI3K signalling in regulatory T cells.
-
批准号:BB/E009867/1
-
项目类别:Research Grant
-
资助金额:$43.83万
-
财政年份:2007
-
负责人:Klaus Okkenhaug
-
依托单位:
国内基金
海外基金
富含半胱氨酸分泌亚家族3蛋白与钙释放通道的相互作用
-
批准号:30870508
-
项目类别:面上项目
-
资助金额:36.0万元
-
批准年份:2008
-
负责人:尹长城
-
依托单位:
信号转导分子PAK4相互作用蛋白质的筛选
-
批准号:30370736
-
项目类别:面上项目
-
资助金额:20.0万元
-
批准年份:2003
-
负责人:李丰
-
依托单位: